MIDDLE EAST RESPIRATORY SYNDROME CoV: AN EVOLVING VIRAL THREAT TO HUMAN HEALTH
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2015, Vol 6, Issue 12
Abstract
The Middle East respiratory syndrome (MERS) is a highly lethal respiratory disease. It is caused by a novel single-stranded, positive-sense RNA betacoronavirus (MERS-CoV). Specific drug treatment exists for MERS and infection prevention and control measures are crucial to prevent spread in health-care facilities.The outbreak of Severe Acute Respiratory Syndrome (SARS) in 2003, led to 8,422 cases and 916 deaths worldwide which highlighted the potential for newly emerging zoonotic coronaviruses to transmit from person one to another, especially in healthcare settings, and to cause severe human illness.MERS-CoV is a novel virus among the genus Betacoronavirus, which was initially identified in Saudi Arabia in September 2012, in two patients with severe pneumonia Upto 7 May 2013, the cases in France were identified, 30 cases had been confirmed as infected by the coronavirus worldwide which included four diagnosed in the United Kingdom (UK) and two in Germany. Two cases of severe respiratory infection have been confirmed as caused by a novel coronavirus. The case guideline has been issued by the World Health Organization (WHO) which is mainly based on acute respiratory illness, pneumonia and travel history. The incubation time is crucial as it is playing a major role in suspecting Saudi Arabia and Qatar, and define its clinical features. The presumed length of the incubation period was compared with known incubation periods of human coronavirus infections including that of severe acute respiratory syndrome (SARS).Our main aim of the article is to give overview on the MERS CoV disease pointing out its symptoms, diagnosis, spread, therapy and cases reported up to now. This is a uncommon virus and details about MERS is still unknown as it is often confused as some common viral respiratory disease so we have tried to collect the possible data and reports in our content.
Authors and Affiliations
Nikita Saraswat, Mohammad Faizan , Rituparna Palit, Pranay Wal
Keywords
Related Articles
- EP ID EP112017
- DOI 10.7897/2230-8407.0612152
- Views 73
- Downloads 0
A COMPREHENSIVE STANDARDIZATION STUDY OF A POLY HERBAL FORMULATION: URAL TABLET
More than half the world’s population is dependent on herbal drugs and in order to enter into the global market it is vital to maintain the quality. Initially the crude drugs were identified by comparison only with the s...
CURRENT TECHNIQUES IN PULSATILE DRUG DELIVERY: A REVIEW
The purpose of writing this review on pulsatile drug delivery system (PDDS) is to compile the recent literatures with special focus on the different types and approaches involved in the development of the formulation and...
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHIC METHOD FOR ESTIMATION OF PANTOPRAZOLE IN INJECTION
A simple and sensitive high performance thin layer chromatography (HPTLC) method has been developed for the quantitative estimation of pantoprazole in its single component injection formulation (40 mg). Pantoprazole chro...
IN SILICO IDENTIFICATION OF NOVEL EGFR TYROSINE KINASE INHIBITORS ASSOCIATED WITH NON-SMALL CELL LUNG CANCER FROM PHYTOCHEMICAL LIBRARY
Inhibition of EGFR by targeting its tyrosine kinase domain is a worldwide accepted treatment of non-small cell lung cancer (NSCLC). Plant derived compounds show excellent potential as cancer growth inhibitors. Present st...
NOVEL ATYPICAL ANTIPSYCHOTIC AGENTS
Antipsychotics are a group of drugs commonly but not exclusively used to treat psychosis. Antipsychotic agents are grouped in two categories: Typical and Atypical antipsychotics. The first antipsychotic was chlorpromazin...